Olivier Godeaux

Olivier Godeaux, MD, MPH, currently serves as Chief Medical Officer at Fab'entech and has extensive experience in medical leadership and clinical development. Godeaux has held senior roles including Sr Medical Monitor/Advisor at Dynavax Technologies and freelance work in Clinical Development, Medical Affairs, Medical Information, and Medical Communication at ZAM Consulting. Previous positions include Chief Medical Officer at Lamina Therapeutics and BONE THERAPEUTICS S.A., and Vaccine Development Leader at UNIVERCELLS. Notably, Godeaux contributed to pivotal RSV vaccine trials at Crucell/Janssen/Johnson and Johnson and was Director of Clinical Development at GSK Vaccines. Godeaux holds a Master in Public Health and a medical degree from Université Catholique de Louvain.